Position in VRTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,442,421
+$1,429,669 QoQ
Shares Held
4,917
+116.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#623
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. VRTX ranks #26 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,442,421 | 4,917 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,012,752 | 2,268 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,132,493 | 2,498 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $939,544 | 2,399 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $551,602 | 1,239 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $638,507 | 1,317 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $317,327 | 788 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $374,389 | 805 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $999,311 | 2,132 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $857,756 | 2,052 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $953,343 | 2,343 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $922,901 | 2,654 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $869,569 | 2,471 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $514,194 | 1,632 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $758,624 | 2,627 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $795,365 | 2,747 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $658,261 | 2,336 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $584,311 | 2,239 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $665,607 | 3,031 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $614,004 | 3,385 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $357,086 | 1,771 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $394,108 | 1,834 | Shares | Other | 2021-05-07 | |
| 2020-12-31 | $771,885 | 3,266 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $962,760 | 3,538 | Shares | Other | 2020-11-05 | |
| 2020-06-30 | $643,035 | 2,215 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $253,654 | 1,066 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||